Daily fish oil supplements do not prevent memory loss or cognitive decline in older adults at risk of Alzheimer’s disease, according to a clinical trial published in the journal eBioMedicine. While researchers from Keck Medicine of USC confirmed that high-dose DHA supplements successfully reach the brain, the study found no measurable improvement in brain volume … Read more
Higher blood plasma levels of vitamin C are associated with better-preserved gray matter and stronger structural connectivity in the brain’s default mode network (DMN), according to a study published in the journal PLOS ONE. Researchers at Hirosaki University in Japan analyzed 2,044 older adults, finding that those with higher vitamin C concentrations exhibited healthier brain … Read more
Understanding the Link Between Anticholinergic Drugs and Dementia Risk Research published in JAMA Internal Medicine indicates that patients aged 55 and over who use strong anticholinergic medications daily for three years or more face a nearly 50% higher risk of developing dementia. The study, conducted by the University of Nottingham and funded by the National … Read more
The New Frontier of Brain Health: Why Age 50+ Is the Critical Window For many, hitting their fifties is a milestone of professional accomplishment and personal freedom. However, for CBS News correspondent Natalie Morales, reaching 53 years of age serves as a poignant reminder of a different priority: proactive brain health. Drawing from her personal … Read more
The New Frontier: Combining Amyloid Clearance with Stem Cell Therapy For years, the fight against Alzheimer’s disease focused almost exclusively on one target: amyloid plaques. The arrival of monoclonal antibody therapies like Leqembi and Kisunla marked a historic milestone, proving we could finally clear these plaques and slow the progression of the disease. View this … Read more
The Great Electrification: Why the World is Shifting Gears For over a century, the global economy has been fueled by the combustion of carbon. But we are witnessing a fundamental pivot. As the International Energy Agency (IEA) recently noted, the world has officially “entered the age of electricity.” This isn’t just about swapping a gas … Read more
Brain’s Immune “Switches” Offer New Hope in Alzheimer’s Fight A groundbreaking study has revealed a surprising link between a brain neurotransmitter, somatostatin, and the immune response in Alzheimer’s disease. Researchers at the Daegu Gyeongbuk Institute of Science and Technology in South Korea have discovered that boosting levels of somatostatin can reduce inflammation and improve cognitive … Read more
Can What You Eat Protect Your Brain? The Emerging Link Between Diet and Alzheimer’s Alzheimer’s disease and other forms of dementia are becoming increasingly prevalent. In Ireland alone, an estimated 64,000 people currently live with dementia, a figure projected to double to 150,000 by 2045. This escalating public health challenge has spurred researchers to explore … Read more
Cognito’s $105 Million Raise: A Glimpse into the Future of Neurological Treatment Cognito Therapeutics’ recent $105 million Series C funding round, led by Morningside Ventures, IAG Capital Partners, and Starbloom Capital, signals growing investor confidence in the potential of non-invasive brain stimulation as a treatment for neurodegenerative diseases. The company, which has now raised $233 … Read more
Alzheimer’s Drug Development: A Recent Wave of Investment and Innovation Despite the recent approval of two amyloid-targeting therapies for Alzheimer’s disease, investors are continuing to bet on new approaches to tackling the devastating condition. Korsana Biosciences, a newly launched company, has secured $175 million in funding to advance its own amyloid-clearing treatment, KRSA-028. The Persistent … Read more